MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/abt/tbag040

Медицинская библиотека · Antibody therapeutics · 2026

Hinge-region Cys-to-Ser mutation enables homogeneous DAR6 anti-c-Met biparatopic ADCs with tolerable O-glycosylation.

Song Deyong, Shen Zhenduo, Zhu Xiaolin, Zhao Haifeng, Wang Yingdi, Zhang Junmei, Li Rui, Xu Hongguang, Cheng Zengjin, Ma Xiaoju, Lin Haixia, Dou Changlin, Xiao Min

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Antibody-drug conjugates (ADCs) with homogeneous drug-to-antibody ratios (DARs) are increasingly favored for their improved physicochemical and pharmacokinetic properties; however, strategies to reliably generate homogeneous DAR6 ADCs remain limited.

METHODS

In this study, we investigate hinge-region cysteine engineering as an approach to constrain conjugation stoichiometry, using a potent biparatopic anti-c-Met antibody as a model. Various biological and physicochemical assays were used for its characterization.

RESULTS

We show that substitution of a hinge-region cysteine within a CPPC (Cysteine - Proline - Proline - Cysteine) motif reduces the number of accessible conjugation sites, allowing reproducible generation of homogeneous DAR6 ADCs. During characterization of Ser- or Thr-substituted hinge variants, we observed additional mass species consistent with mucin-type O-linked glycosylation. Site-specific mass spectrometry analyses localized these modifications to a serine residue within hinge-region and identified the core structures of the O-glycans. Analysis of additional antibodies carrying analogous mutations demonstrated that hinge-associated O-glycosylation is not restricted to a single antibody scaffold.

CONCLUSIONS

These results demonstrate that hinge-region cysteine engineering can serve as a rational and adaptable approach for DAR6 ADC development while highlighting the need for case-by-case evaluation of associated post-translational modifications during antibody engineering.

Для цитирования: Song Deyong, Shen Zhenduo, Zhu Xiaolin, Zhao Haifeng, Wang Yingdi, Zhang Junmei, Li Rui, Xu Hongguang, Cheng Zengjin, Ma Xiaoju, Lin Haixia, Dou Changlin, Xiao Min. Hinge-region Cys-to-Ser mutation enables homogeneous DAR6 anti-c-Met biparatopic ADCs with tolerable O-glycosylation.. Antibody therapeutics. 2026. DOI: 10.1093/abt/tbag040.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.